Walgreens connects a $ 10 billion contract with Sycamore partners

Drugs fight with Darks chain Walgreens It goes a personal.

The company told that on Thursday An agreement With a personal capital firm, Sycamore partners, which will leave the public market for a capital cost of about $ 10 billion.

Sycamore will pay $ 11.45 per cash for Walgreens, which represents about 8% award for the price of the stock market on Thursday. Shareholders may be up to $ 3 more than the sale of Walgreens primary care facilities, including village medical care, summit health and CityMDs.

Walgreens said that the operation will be up to $ 23.7 billion, including the total cost, debt and possible payments.

Walgreens and Sycamore are waiting to close the peculiarity deal in the fourth quarter of this year. The shares of Walgreens jumped more than 5% after trade after being stopped on Thursday.

The historical deal as a folk company that started in 1927, Walgreens’in “Harmful Run, 2025 shares were more than 15% for 2025 and fell to 70% in the last three years.

“When making progress against our ambitious turning strategy, creating a meaningful value, better management and change, such as a private company,” Walgreens CEO Tim Wentworth, who entered Thursday, he said. “Sycamore will provide a partner’s experience and experience with a strong trace of successful retailers.

Stefan Kaluzny, Sycamore’s management director, release of the operation, reflecting the trust of the firm’s Walgreens’ “Eczane-LED Models and Patients play an important role in better results for customers and communities.”

Walgreens will protect the headquarters in Chicago. The company currently has more than 310,000 employees in the United States, Europe and Latin America, Europe and Latin America. Walgreens still plans to release second quarterly earnings on April 8.

The market value of Walgreens has reached more than $ 100 billion in 2015, as investor gained confidence in health care and expansion plans and makes it one of the most famous American retailers.

However, the market cover started in late 2024, its main rival CVs, broker chains, large box retailers and AmazonIn addition to a problem. Walgreens, Covid Pandemic, pharmacy compensation headlines, softened consumer expenses and transitions by linking to the health status.

Both Walgreens and CV caused the expansion of shares with shops to close hundreds of retailers on the bank’s retailer. However, unlike CVs that diversify the business model by offering insurance and pharmacy benefits, Walgreens, now the talenter has increased twice in retail pharmacy.

In October, Walgreens said it was planning Pharmacy No. 1200 Over the next three years, including 500 in 2025 Finance 2025. Walgreens, the 8,700th place in the United States, is harmless to say one quarter. The company cut his share in the provider in the provider and returned the candle to the main care.

Walgreens, as the new CEO of 2023 in late 2023, Walgreens veteran Tim Wentworth, as the CEO of 2023.

The company said it was seen as a potential characteristic target in the past.

In 2019, KKR prepared a private capital company quart $ 70 billion purchase Offer to Walgreens, financial times and offer to Bloomberg.